Art

J-GLOBAL ID：200902212414734439   Reference number：07A0768800

The effects of Maxacalcitol therapy for the patients with secondary hyperparathyroidism on clinical symptoms, bone mineral density and parathyroid swelling

二次性副甲状腺機能亢進症に対するMaxacalcitol(オキサロール)による静注パルス療法は臨床症状,骨塩量の改善と副甲状腺の縮小に効果があるか

Author (5)： YASUNAGA CHIKAO (福岡県済生会 八幡総合病院 腎セ) ,  MATSUO KENZO (八幡クリニック) ,  TANAKA HIROSHI (医生ケ丘クリニック) ,  BABA MITSUO (済生会 八幡総合病院 内科) ,  NAKAMOTO MASAHIKO (田川市病院)
Material： 日本透析医学会雑誌  (Journal of Japanese Society for Dialysis Therapy)
Volume： 40  Issue： 7  Page： 573-579  Publication year： Jul. 28, 2007 
JST Material Number： X0954A  ISSN： 1340-3451  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *vitamin D ,...
Semi thesaurus term： *hyperparathyroidism syndrome ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=07A0768800&from=J-GLOBAL&jstjournalNo=X0954A") }}

JST classification (2)： Drug therapy(=pharmacotherapy)for endocrine diseases  (GL05020S) ,  Treatment for urogenital in general  (GM05010K)

Substance index (2)： Maxacalcitol ,  Calcitriol

Reference (17)：

• SLATOPOLSKY, E. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25 dihydroxycholecarciferol in uremic patients. J Clin Invest. 1984, 74, 2136-2143
• BROWN, AJ. Therapeutic uses of vitamin D analogues. Am J Kidney Dis. 2001, 38, S3-S19
• FUKAGAWA, M. Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients. Nephron. 1994, 68, 221-228
• CANNELLA, G. Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzied uremic patients treated with long-term intravenous calcitriol. Kidney Int. 1994, 46, 1124-1132
• KATOH, N. Presence of sonographically detectable parathyroid glands can predict resistance to oral pulsed-dose calcitriol treatment of secondary hyperparathyroidism. Am J Kidney Dis. 2000, 35, 465-468

Terms in the title (8)： 二次性副甲状腺機能亢進症 ,  オキサロール ,  静注 ,  パルス療法 ,  臨床症状 ,  骨塩量 ,  副甲状腺 ,  縮小